4//SEC Filing
Zhang Ping 4
Accession 0001140361-25-029693
CIK 0001124105other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 8:00 PM ET
Size
5.4 KB
Accession
0001140361-25-029693
Insider Transaction Report
Form 4
Zhang Ping
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-08-05+250,000→ 250,000 totalExercise: $6.92Exp: 2035-08-05→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 250,000 shares of the Issuer's common stock, 25% of which will vest on August 5, 2026, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
GYRE THERAPEUTICS, INC.
CIK 0001124105
Entity typeother
Related Parties
1- filerCIK 0002050176
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 8:00 PM ET
- Size
- 5.4 KB